Health Canada - Federal department responsible for drug approvals and health regulation in Canada
显示 2024 年的审批记录
仅限当前页。暂不支持搜索完整审批数据集。
药物名称 | 公司 | 适应症 | 日期 | 类型 |
|---|---|---|---|---|
| MYLAN-ATAZANAVIR | Mylan Pharmaceuticals ULC | Marketed | May 3, 2017 | Marketed |
| ELIMINATE | DUSTBANE PRODUCTS LTD | Marketed | May 2, 2017 | Marketed |
| RIXUBIS | takeda canada inc | Dormant | May 2, 2017 | Dormant |
| MYLAN-ATAZANAVIR | Mylan Pharmaceuticals ULC | Marketed | May 2, 2017 | Marketed |
| APO-OLMESARTAN/HCTZ | Apotex Inc | Marketed | May 2, 2017 | Marketed |
| TECENTRIQ | Hoffmann-La Roche Limited | Marketed | May 2, 2017 | Marketed |
| APO-OLMESARTAN/HCTZ | Apotex Inc | Marketed | May 2, 2017 | Marketed |
| BRAVECTO | Intervet Canada Corp | Marketed | May 1, 2017 | Marketed |
| AURO-OLMESARTAN | auro pharma inc | Marketed | May 1, 2017 | Marketed |
| TEVA-OLMESARTAN / HCTZ | teva canada limited | Marketed | May 1, 2017 | Marketed |
| TEVA-OLMESARTAN | teva canada limited | Marketed | May 1, 2017 | Marketed |
| TEVA-OLMESARTAN | teva canada limited | Marketed | May 1, 2017 | Marketed |
| TEVA-OLMESARTAN / HCTZ | teva canada limited | Marketed | May 1, 2017 | Marketed |
| TEVA-OLMESARTAN / HCTZ | teva canada limited | Marketed | May 1, 2017 | Marketed |
| SANDOZ OLMESARTAN | Sandoz Canada, Inc. | Marketed | May 1, 2017 | Marketed |
| SANDOZ OLMESARTAN | Sandoz Canada, Inc. | Marketed | May 1, 2017 | Marketed |
| AURO-OLMESARTAN | auro pharma inc | Marketed | May 1, 2017 | Marketed |
| MULTI-SURFACE DISINFECTANT | GEMINI PACKAGING LTD | Marketed | Apr 30, 2017 | Marketed |
| CAVILON DURABLE BARRIER CREAM | 3 m healthcare canada company limited | Marketed | Apr 28, 2017 | Marketed |
| LIXIANA | SERVIER CANADA INC | Cancelled Post Market | Apr 25, 2017 | Cancelled Po... |
